Teva Advances U.S. Deal on Affordable Medicines and Supply
PARSIPPANY, N.J., and TEL AVIV, Israel, August 31, 2026 Teva Pharmaceuticals announced a shared commitment with the Trump Administration...
Affordable medicines
Advertisement
Grifols Completes SPARTA Phase 3 Trial of Prolastin-C
Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...
Amneal Completes Kashiv BioSciences Acquisition to Expand Biosimilars
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
Par Health Launchs First FDA-Approved Generic Janumet® XR in U.S.
ST. LOUIS – July 24, 2026 Par Health, Inc. has announced the U.S. launch of its generic version of...
Accord BioPharma Launches Two Denosumab Biosimilars
RALEIGH, N.C., July 23, 2026 Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has announced the commercial...
Advertisements
Lupin Wins Tentative FDA Approval for COPD Inhalation Therapy Revefenacin
MUMBAI, India and NAPLES, Fla., May 18, 2026 Lupin Limited has announced that it has received tentative approval from...
Sandoz Secures EC Approval for Bysumlog and Dazparda Diabetes Biosimilars
BASEL, Switzerland, May 15, 2026 Sandoz has announced that the European Commission (EC) granted marketing authorization for two biosimilar...
DifGen, Apotex Win FDA Approval for Nintedanib Capsules
MIRAMAR, Fla., April 9, 2026 DifGen Pharmaceuticals LLC, in collaboration with Apotex Inc., has announced that the U.S. Food...
Amneal Wins FDA Nod for Sodium Oxybate, Expanding Access to Narcolepsy Therapy
RIDGEWATER, N.J., September 11, 2025 – Amneal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Private Equity Firm GTCR to Acquire Zentiva from Advent, Expanding Pharma Reach
Prague, Czech Republic; London, UK; Chicago, US – September 11, 2025 – Zentiva, a leading European generics pharmaceutical company,...
Advertisement
